Innovotech gets $234K NRC funding to develop advanced antimicrobial testing for medical devices.

Innovotech Inc.'s subsidiary, Innovotech Labs, received up to $234,000 CAD from the National Research Council of Canada to develop new antimicrobial testing services for medical devices like catheters and implants. These tests align with updated international standards and help manufacturers better assess device safety and performance. The funding supports enhanced testing that reflects real-world use, aiding regulatory compliance and improving health outcomes by reducing infections. This advancement strengthens Innovotech's service offerings and technical capabilities amid rising client demand.